Finance

Lists
CRDF:NASDAQ
Cardiff Oncology Inc
0,93 $
-1,17%
(-0,011) 1D
22 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDF...
Open
0,93 $
High
0,97 $
Low
0,91 $
Mkt. cap
72,12 մլն
Avg. vol.
702,30 հզր
Volume
228,68 հզր
52-wk high
3,30 $
52-wk low
0,76 $
EPS
-0,59 $
Beta
1,42
Shares outstanding
77,80 մլն
No. of employees
31
Open
0,93 $
High
0,97 $
Low
0,91 $
Mkt. cap
72,12 մլն
Avg. vol.
702,30 հզր
Volume
228,68 հզր
52-wk high
3,30 $
52-wk low
0,76 $
EPS
-0,59 $
Beta
1,42
Shares outstanding
77,80 մլն
No. of employees
31
News stories
From web sources and news partners
About Cardiff Oncology Inc
CEOMark Erlander
Employees31
Founded1999
Headquarters-
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to CRDF in the past 3 months
Buy
Buy
2
Hold
3
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CRDF in the last 3 months.
Highest
Current 0,93 $
9,00 $ (+869,83%)
Average
7,50 $ (+708,19%)
Lowest
6,00 $ (+546,55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
09/15/2026
Robert Burns
H.C. Wainwright
Buy
Upgraded
9,00 $
+869,8%
09/15/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
09/14/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
6,00 $
+546,6%
08/12/2026
Marc Frahm
TD Cowen
Hold
Maintained
-
-
08/12/2026
Christopher Liu
Lucid Capital
Buy
Maintained
4,00 $
+331%
06/05/2026
Robert LeBoyer
Noble Financial
Buy
Reiterated
12,00 $
+1 193,1%
05/22/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
120,00 հզր
243,00 հզր
41,00 հզր
104,00 հզր
Cost of goods sold
8,20 մլն
5,08 մլն
-
-
Cost of revenue
8,20 մլն
5,08 մլն
-
-
Research and development expenses
-
-
6,76 մլն
5,92 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,90 մլն
3,00 մլն
6,13 մլն
3,80 մլն
Operating expense
3,90 մլն
3,00 մլն
12,89 մլն
9,72 մլն
Total operating expenses
12,09 մլն
8,07 մլն
12,89 մլն
9,72 մլն
Operating income
-11,97 մլն
-7,83 մլն
-12,85 մլն
-9,62 մլն
Other non operating income
-
-1,00 հզր
-1,00 հզր
1,00 հզր
EBT including unusual items
-11,26 մլն
-7,22 մլն
-12,34 մլն
-9,23 մլն
EBT excluding unusual items
-11,26 մլն
-7,22 մլն
-12,34 մլն
-9,23 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-11,26 մլն
-7,22 մլն
-12,34 մլն
-9,23 մլն
Net profit margin
-9 381,67%
-2 969,55%
-30 109,76%
-8 876,92%
Earnings per share
-0,17
-0,11
-0,18
-0,14
Interest and investment income
716,00 հզր
612,00 հզր
506,00 հզր
382,00 հզր
Interest expense
-
-
-
-
Net interest expenses
716,00 հզր
612,00 հզր
506,00 հզր
382,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-11,88 մլն
-7,74 մլն
-12,76 մլն
-9,53 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps